Endometrial cancer in Olmsted County, MN: Trends in incidence, risk factors and survival

Annals of Epidemiology

Volumn 10, Issue 2, 2000, Pages 97-105

  Beard, C Mary ^a   Hartmann, Lynn C ^a   Keeney, Gary L ^a   Crowson, Cynthia S ^a   Malkasian, George D ^a   O'Brien, Peter C ^a   Melton III, L Joseph ^a  

^a MAYO CLINIC   (United States)

Author keywords

Endometrial cancer; Epidemiology; Incidence; Risk factors; Survival

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; POPULATION; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES;

CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYSTERECTOMY; INCIDENCE; LOGISTIC MODELS; MINNESOTA; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0033983711     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(99)00039-3     Document Type: Article

References (42)

1. Sondik EJ, Young JL, Horm JW, Gloeckler Ries LA. 1986 Annual Cancer Statistics Review [NIH Publication No. 87-2789]. Bethesda, MD: National Cancer Institute, U.S. Department of Health and Human Services, National Institutes of Health; 1987:II.B.25-II.B26.
2. Marrett L.D., Meigs J.W., Flannery J.T. Trends in the incidence of cancer of the corpus uteri in Connecticut, 1964-1979, in relation to consumption of exogenous estrogen. Am J Epidemiol. 116:1982;57-67.
3. Austin D.F., Roe K.M. The decreasing incidence of endometrial cancer. Public health implications Am J Public Health. 72:1982;65-68.
4. McDonald T.W., Annegers J.F., O'Fallon W.M., Dockerty M.B., Malkasian G.D. Jr., Kurland L.T. Exogenous estrogen and endometrial carcinoma. Case-control and incidence study Am J Obstet Gynecol. 127:1977;572-580.
5. SEER Stat 2.0 CD-ROM: SEER Cancer Incidence Public-Use Database, 1973-1996. Issued April 1999. Bethesda, MD: National Cancer Institute; 1999.
6. Hemminki E., Kennedy D.L., Baum C., McKinlay S.M. Prescribing of noncontraceptive estrogens and progestins in the United States, 1974-86. Am J Public Health. 78:1988;1479-1481.
7. Melton L.J. III History of the Rochester Epidemiology Project. Mayo Clin Proc. 71:1996;266-274.
8. Kurland L.T., Molgaard C.A. The patient record in epidemiology. Sci Am. 245:1981;54-63.
9. Creasman W.T. New gynecologic cancer staging. Obstet Gynecol. 75:1990;287-288.
10. Pokras V, Hufragel V. Hysterectomies in the United States, 1965-84. In: Vital & Health Statistics, Data from the National Health Survey, Series 13, No. 92, DHHS Publication No. (PHS) 88-1753. Washington DC: U.S. Government Printing Office; 1987.
11. Bergstralh E.J., Offord K.P., Chu C.P., Beard C.M., O'Fallon W.M., Melton L.J. III Calculating incidence, prevalence and mortality rates for Olmsted County, Minnesota. An Update:1992;Mayo Clinic, Section of Biostatistics, Rochester, MN. [Technical Report No. 49].
12. Breslow NE, Day NE. Statistical Methods in Cancer Research. v. 2. The Analysis of Case-Control Studies. Lyon: IARC Scientific Publication #32; 1980.
13. Bruzzi P., Green S.B., Byar D.P., Brinton L.A., Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol. 122:1985;904-914.
14. Kaplan E.L., Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
15. O'Brien P.C., Fleming T.R. A paired Prentice-Wilcoxon test for censored paired data. Biometrics. 43:1987;169-180.
16. Vessey M.P., Lawless M. Epidemiology of endometrial cancer. Morrow C.P., Smart G.E. Gynaecological Oncology. 1986;127-136 Springer-Verlag, New York.
17. Kneale B.L.G., Giles G.G. Endometrial cancer. Trends in incidence and survival: A preventable disease? Australian NZJ Obstet Gynaecol. 33:1993;1-7.
18. Kelsey J.L., Whittemore A.S. Epidemiology and primary prevention of cancers of the breast, endometrium, and ovary. A brief overview. Ann Epidemiol. 4:1994;89-95.
19. Salmi T. Endometrial carcinoma risk factors, with special reference to the use of oestrogens. Acta Endocrinol. 94(suppl 233):1980;37-43.
20. Koumantaki Y., Tzonou A., Koumantakis E., Kaklamani E., Aravantinos D., Trichopoulos D. A case-control study of cancer of endometrium in Athens. Intl J Cancer. 43:1989;795-799.
21. Brinton L.A., Hoover R.N. Estrogen replacement therapy and endometrial cancer risk. Unresolved issues. The Endometrial Cancer Collaborative Group Obstet Gynecol. 81:1993;265-271.
22. Törnberg S.A., Carstensen J.M. Relationship between Quetelet's index and cancer of breast and female genital tract in 47,000 women followed for 25 years. Br J Cancer. 69:1994;358-361.
23. Trapido E.J. A prospective cohort study of oral contraceptives and cancer of the endometrium. Intl J Epidemiol. 12:1983;297-300.
24. Ory H.W., Layde P.M., Webster L.A., Wingo P.A., Scally M.J., Glatzer M.et al. Oral contraceptive use and the risk of endometrial cancer. The Centers for Disease Control and Steroid Hormone Study JAMA. 249:1983;1600-1604.
25. Beral V., Hannaford P., Kay C. Oral contraceptive use and malignancies of the genital tract. Results from the Royal College of General Practitioners Oral Contraception Study Lancet. 2:1988;1331-1335.
26. Kaufman D.W., Shapiro S., Slone D., Rosenberg L., Miettinen O.S., Stolley P.D.et al. Decreased risk of endometrial cancer among oral-contraceptive users. N Engl J Med. 303:1980;1045-1047.
27. Weiss N.S., Sayvetz T.A. Incidence of endometrial cancer in relation to the use of oral contraceptives. N Engl J Med. 302:1980;551-554.
28. Lesko S.M., Rosenberg L., Kaufman D.W., Helmrich S.P., Miller D.R., Strom B.et al. Cigarette smoking and the risk of endometrial cancer. N Engl J Med. 313:1985;593-596.
29. Brinton L.A., Berman M.L., Mortel R., Twiggs L.B., Barrett R.J., Wilbanks G.D.et al. Reproductive, menstrual, and medical risk factors for endometrial cancer. Results from a case-control study Am J Obstet Gynecol. 167:1992;1317-1325.
30. McPherson C.P., Sellers T.A., Potter J.D., Bostick R.M., Folsom A.R. Reproductive factors and risk of endometrial cancer. The Iowa Women's Health Study Am J Epidemiol. 143:1996;1195-1202.
31. Ganguly S.S., Naik-Nimbalkar U.V. Analysis of ordinal data in a study of endometrial cancer under a matched pairs case-control design. Stat Med. 14:1995;1545-1552.
32. Persson I., Adami H.-O., Bergkvist L., Lindgren A., Pettersson B., Hoover R.et al. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens. Results of a prospective study BMJ. 298:1989;147-151.
33. Beard C.M., Kottke T.E., Annegers J.F., Ballard D.J. The Rochester Coronary Heart Disease Project. Effect of cigarette smoking, hypertension, diabetes, and steroidal estrogen use on coronary heart disease among 40- to 59-year-old women, 1960 through 1982 Mayo Clin Proc. 64:1989;1471-1480.
34. Beard C.M., Orencia A., Kottke T., Ballard D.J. Body mass index and the initial manifestation of coronary heart disease in women aged 40-59 years. Intl J Epidemiol. 21:1992;656-664.
35. Horwitz R.I., Feinstein A.R. Alternative analytic methods for case-control studies of estrogen and endometrial cancer. N Engl J Med. 299:1978;1089-1094.
36. Parazzini F., Negri E., La Vecchia C., Bruzzi P., Decarli A. Population-attributable risk for endometrial cancer in Northern Italy. Eur J Cancer Clin Oncol. 25:1989;1451-1456.
37. Chu J., Schweid A.I., Weiss N.S. Survival among women with endometrial cancer. A comparison of estrogen users and nonusers Am J Obstet Gynecol. 143:1982;569-573.
38. Collins J., Donner A., Allen L.H., Adams O. Oestrogen use and survival in endometrial cancer. Lancet. 2:1980;961-964.
39. Kauppila A., Grönroos M., Nieminen U. Clinical outcome in endometrial cancer. Obstet Gynecol. 60:1982;473-480.
40. Persson I., Adami H.-O., Malker B., Pettersson B. Long-term survival in endometrial cancer with special reference to age as a prognostic factor. Ups J Med Sci. 89:1984;159-170.
41. Malkasian G.D., Annegers J.F., Fountain K.S. Carcinoma of the endometrium. Stage I Am J Obstet Gynecol. 136:1980;872-888.
42. Kosary C.L. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system. An analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina Sem Surg Oncol. 10:1994;31-46.